Cytogenetic and molecular study of 32 Down syndrome families: potential leukaemia predisposing role of the most proximal segment of chromosome 21q

被引:17
作者
Cavani, S
Perfumo, C
Argusti, A
Pierluigi, M
Perroni, L
Scmiegelow, K
Petersen, MB
Cotter, FE
Strigini, P
Dagna-Bricarelli, F
Nizetic, D
机构
[1] Galliera Hosp, Human Genet Lab, I-16128 Genoa, Italy
[2] Rigshosp, Dept Paediat, DK-2100 Copenhagen, Denmark
[3] John F Kennedy Inst, Dept Med Genet, DK-2600 Glostrup, Denmark
[4] Aghia Sophia Childrens Hosp, Inst Child Hlth, Athens, Greece
[5] Inst Child Hlth, Leukaemia Res Fund, London, England
[6] Natl Inst Canc Res, Genoa, Italy
[7] Univ London, Sch Pharm, Ctr Appl Mol Biol, London WC1E 7HU, England
关键词
trisomy; 21; Down syndrome leukaemia; ANLL (M7); 21q11; disomic homozygosity;
D O I
10.1046/j.1365-2141.1998.00924.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Down syndrome (DS) children have a 10-20-fold increased risk of developing ALL or AML compared to non-DS children. An increased disomic homozygosity of the polymorphic DNA markers in the pericentromeric region of chromosome 21q (21q11) has repeatedly been found in DS patients with ANLL-M7 and DS-specific transient abnormal myelopoiesis (TAM), compared to the majority of DS subjects without leukaemia. Analysis of cytogenetic heteromorphisms and 26 polymorphic DNA markers from chromosome 21q showed an increased number of pericentromeric crossovers between the non-disjoined chromosomes in DS-ANLL cases (3/11), compared to DS-ALL (0/9) and DS-nonleukaemic cases (0/12), These findings are compatible with the model of disomic homozygosity of the predisposing allele of a putative pericentromeric gene, as an explanation for the high prevalence of ANLL in DS.
引用
收藏
页码:213 / 216
页数:4
相关论文
共 12 条
[1]  
ABE K, 1989, HUM GENET, V82, P313
[2]   DOWNS-SYNDROME AND LEUKEMIA - EPIDEMIOLOGY, GENETICS, CYTOGENETICS AND MECHANISMS OF LEUKEMOGENESIS [J].
FONG, C ;
BRODEUR, GM .
CANCER GENETICS AND CYTOGENETICS, 1987, 28 (01) :55-76
[3]   SIMULTANEOUS OCCURRENCE OF MONGOLISM AND LEUKEMIA - REPORT OF A NATIONWIDE SURVEY [J].
KRIVIT, W ;
GOOD, RA .
AMA JOURNAL OF DISEASES OF CHILDREN, 1957, 94 (03) :289-293
[4]   Characterization of susceptible chiasma configurations that increase the risk for maternal nondisjunction of chromosome 21 [J].
Lamb, NE ;
Feingold, E ;
Savage, A ;
Avramopoulos, D ;
Freeman, S ;
Gu, Y ;
Hallberg, A ;
Hersey, J ;
Karadima, G ;
Pettay, D ;
Saker, D ;
Shen, J ;
Taft, L ;
Mikkelsen, M ;
Petersen, MB ;
Hassold, T ;
Sherman, SL .
HUMAN MOLECULAR GENETICS, 1997, 6 (09) :1391-1399
[5]   A population-based study of 272 children with acute myeloid leukaemia treated on two consecutive protocols with different intensity: Best outcome in girls, infants, and children with Down's syndrome [J].
Lie, SO ;
Jonmundsson, G ;
Mellander, L ;
Siimes, MA ;
Yssing, M ;
Gustafsson, G .
BRITISH JOURNAL OF HAEMATOLOGY, 1996, 94 (01) :82-88
[6]   CHARACTERIZATION AND MOLECULAR ANALYSIS OF NONDISJUNCTION IN 18 CASES OF TRISOMY-21 AND LEUKEMIA [J].
LORBER, BJ ;
FREEMAN, SB ;
HASSOLD, T ;
RAGAB, AH ;
VEGA, RA ;
COCKWELL, AE ;
JACOBS, PA ;
RADFORD, M ;
DOYLE, J ;
DUBE, ID ;
ZIPURSKY, A .
GENES CHROMOSOMES & CANCER, 1992, 4 (03) :222-227
[7]  
NIIKAWA N, 1991, HUM GENET, V87, P561
[8]  
ROBINSON LL, 1987, ONCOLOGY IMMUNOLOGY, P19
[9]  
SHEN JJ, 1995, AM J HUM GENET, V56, P915
[10]  
SHIMIZU N, 1995, CYTOGENET CELL GENET, V70, P147